Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).
about
Evaluation of the Effects of Vaccinium arctostaphylos L. Fruit Extract on Serum Lipids and hs-CRP Levels and Oxidative Stress in Adult Patients with Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialStatins for primary prevention of venous thromboembolismStatins for the primary prevention of cardiovascular diseaseStatins for primary prevention of venous thromboembolismPleiotropic effects of statinsState of the art in carotid artery stenting: trial data, technical aspects, and limitations.Safety of statins: an updateC-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke studyBenefits of statin therapy and compliance in high risk cardiovascular patients.Inflammatory mechanisms of stroke.Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats.My patient has an elevated hs-CRP. What does this mean? What should I do now?Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA StudyEffects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.Pleiotropic effects of the HMG-CoA reductase inhibitorsStatins for the prevention of stroke: a meta-analysis of randomized controlled trials.JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses.C-reactive protein and long-term ischemic stroke prognosis.Treatment of risk factors to prevent stroke.Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietinChanges in stroke epidemiology, prevention, and treatment.Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer preventionAssociation Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men.Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial.Perioperative stroke.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study.Comparison of the efficacy and safety of intensive-dose and standard-dose statin treatment for stroke prevention: A meta-analysis.Evaluation of the Effectiveness of a Patient-Centered Educational Mailer Designed to Improve Statin Adherence: A Pragmatic Trial.Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.The role of statins in stroke.Current role of biomarkers in carotid disease: a systematic review.Statins in hemorrhagic stroke.The role of intima-media-thickness, ankle-brachial-index and inflammatory biochemical parameters for stroke risk prediction: a systematic review.Role of C-reactive protein in cerebrovascular disease: a critical review.Cardiovascular disease, statins and vitamin D.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.Potential role for statins in sickle cell disease.Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.Advances in stroke prevention.
P2860
Q21284725-C36B57D9-592A-4EC1-AF41-E909E8D4A068Q24187238-6E11DE79-CE61-40A9-AA2E-C5DC89603C66Q24201513-E1B0A951-43FD-4206-9D3B-96CB0273FDF5Q24204040-04D4B397-52CC-4FD1-87E2-F2B60DB0807BQ26783220-A46F04B0-8332-4C8E-B855-EC0EF0242D73Q30810161-455F18E4-40E2-4FF8-B038-7FCC96B7B88DQ33949312-2058D806-5E13-4E4E-BF7C-89AF7E12ED3AQ33966178-79271FE6-BC60-4A9E-915B-B8BCA438D14AQ34187551-DDBB8AB0-BF05-4D4E-B7AA-5C1F564579D1Q34235537-AFD85C43-FBA0-47FB-B279-3CC7F0DF6CEFQ34311404-34143EED-3ABA-4C5C-804C-2AD492237587Q34481383-67FEBA86-E390-4F07-8905-A5E4BCFE718BQ34626188-2E5EFBBA-6EE7-4EAA-A036-E496692E6197Q34709177-F0BBCF53-8439-4A2A-91AB-928D410512B1Q34894749-36E97733-7099-4DC6-939D-84DE810ECCDAQ35124353-F5264825-4870-4093-AF9E-8824798773EEQ35172886-57931D3D-83A4-47DA-A7F8-A711C4D12E81Q35379531-842FAC68-7D1B-496D-AF23-D50F8215DD2BQ35648075-5F35BEA8-EE92-4825-876A-5273671D4185Q35777054-BEA88E59-2F56-4783-AEE9-B9BFF7B66864Q35850235-E4B4E0C0-30E5-44CC-847D-556E3B92418BQ36080332-20557959-8FC8-45EC-BA13-7707DE8469A6Q36141776-9F5E85BB-0471-46F7-913C-04B7619EF4ACQ36469959-D2CC3E14-57CE-4EC3-BC0E-3E48AB24F553Q36483865-FBEEECCF-E955-4088-B737-96EC5C693642Q37251490-1E4C0B7A-C653-4DD6-A106-A913253195D3Q37345221-1E50944E-B5CE-4AFD-A259-9BB286729AACQ37605860-5E667AB0-B198-4A14-8E51-56BA7C069F6CQ37636522-9D8D6218-D259-4B8C-B992-7D4575D57981Q37707415-656E6706-B451-4148-8163-0250240E712AQ37872224-51824188-CA05-4D3C-88E7-8653DCE088E3Q37899952-D24912DF-C85A-4514-9C68-C70BA4A44341Q37907293-711A0347-B0A0-45CE-9D05-31B2C493C26BQ37927179-D022F139-524B-4B4B-A464-BEBA4066DFE7Q37959060-AE9F5992-1B28-4DDB-B952-3CA81E633461Q37991512-766E1A93-D7ED-420C-9235-76098945EBE0Q38020536-9B0DEEC3-B608-4C96-8F74-9BF293337D13Q38071047-EADCB310-17A3-4B21-89E5-EE12E21D0E24Q38208727-773A650D-359F-4DEC-9B1D-66FE955759CEQ38380852-58CB6790-2DA7-4539-B542-C982C55F06CA
P2860
Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@ast
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@en
Rosuvastatin in the prevention ...... Trial Evaluating Rosuvastatin
@nl
type
label
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@ast
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@en
Rosuvastatin in the prevention ...... Trial Evaluating Rosuvastatin
@nl
prefLabel
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@ast
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@en
Rosuvastatin in the prevention ...... Trial Evaluating Rosuvastatin
@nl
P2093
P1433
P1476
Rosuvastatin in the prevention ...... uating Rosuvastatin (JUPITER).
@en
P2093
Brendan M Everett
Jean G MacFadyen
Paul M Ridker
Robert J Glynn
P304
P356
10.1161/CIRCULATIONAHA.109.874834
P407
P577
2009-12-21T00:00:00Z